Lv2
106 积分 2021-06-24 加入
POS0214 A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2/3 STUDY OF SHR0302, A SELECTIVE JANUS KINASE 1 INHIBITOR, IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS
4个月前
已关闭
[Chinese expert consensus on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors]
5个月前
已完结
Crosslinking Enzyme Lysyl Oxidase Modulates Scleral Remodeling in Form-Deprivation Myopia
8个月前
已完结
A review of atropine for the treatment of myopia
1年前
已完结
Benefits and limitations of the low dose atropine use
1年前
已关闭
The safety of atropine for myopia prevention and control
1年前
已完结
皖公网安备34019202002308
